NASDAQ · Medical - Instruments & Supplies

PDEX (PDEX) Stock

$63.61 +8.61% NASDAQ: PDEX Healthcare

Valuation

MetricValue
Price$63.61
Market Cap$203.09M
P/E Ratio17.11
P/B Ratio4.39
P/S Ratio2.66
EPS (TTM)$3.63
52-Week High$68.99
52-Week Low$23.47
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE29.83%
ROA9.70%
ROCE30.56%
Gross Margin27.78%
Operating Margin14.48%
Net Margin16.08%
Debt/Equity0.45
Current Ratio3.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$42.0M$46.0M$54.0M$67.0M
Operating Profit$5.0M$5.0M$6.0M$7.0M$11.0M
Net Profit$5.0M$5.0M$7.0M$2.0M$9.0M
EPS$1.13$1.21$1.95$0.60$2.67
Op Margin12.2%12.2%12.5%13.3%16.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$49.0M$49.0M$52.0M$52.0M$61.0M
Total Liabilities$24.0M$24.0M$20.0M$22.0M$25.0M
Cash$1.0M$1.0M$3.0M$3.0M$0
Borrowings$16.0M$16.0M$15.0M$14.0M$17.0M

Latest News

Pro-Dex, Inc. Announces Fiscal 2026 Third Quarter and Nine Month Results ACCESS Newswire · Apr 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$5.0M$6.0M$-2.0M
Investing Cash Flow$-3.0M$-3.0M$-2.0M$-3.0M$-1.0M
Financing Cash Flow$-10.0M$-2.0M$-2.0M$-3.0M$-4.0M
Net Cash Flow$-3.0M$-3.0M$2.0M$0$-2.0M
Free Cash Flow$-3.0M$-3.0M$4.0M$5.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio5.31
EV / EBITDA17.16
FCF Yield3.51%
Quick Ratio2.14
Interest Coverage11.00
Return 1Y26.02%
Return 3Y215.43%
Return 5Y102.15%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APYX $4.07 -1.21% -17.90 $171.39M 0.00%
CGTX $0.89 +0.21% -3.94 $79.79M 0.00%
GLSI $14.36 +0.84% -21.98 $210.78M 0.00%
IXHL $2.99 +1.19% -0.09 $35.71M 0.00%
LUCD $0.97 +1.47% -1.45 $98.94M 0.00%

About PDEX

PDEX is led by CEO Richard Lee Van Kirk Jr., publicly traded since 1986.

PDEX stock trades at $63.61 with a market capitalization of $203.09M. The stock is valued at a price-to-earnings (P/E) ratio of 17.11, price-to-book of 4.39, price-to-sales of 2.66. Over the past 52 weeks the stock has ranged between $23.47 and $68.99, and currently trades 7.8% below its 52-week high.

On profitability, PDEX generates a return on equity (ROE) of 29.83% — well above the market average, a sign of a high-quality business, return on capital employed of 30.56%, an operating margin of 14.48%, a net profit margin of 16.08%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides